These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6213426)

  • 1. On the structure of the stable complex between plasmin and alpha-2-antiplasmin.
    Nilsson T; Wiman B
    FEBS Lett; 1982 Jun; 142(1):111-4. PubMed ID: 6213426
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulfation of a tyrosine residue in the plasmin-binding domain of alpha 2-antiplasmin.
    Hortin G; Fok KF; Toren PC; Strauss AW
    J Biol Chem; 1987 Mar; 262(7):3082-5. PubMed ID: 2434496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin.
    Rijken DC; Groeneveld E; Kluft C; Nieuwenhuis HK
    Biochem J; 1988 Oct; 255(2):609-15. PubMed ID: 2974279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
    Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
    Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of the inhibition of plasmin in acidified human plasma.
    Lijnen HR; Maes M; Castel M; Samama M; Collen D
    Thromb Haemost; 1982 Dec; 48(3):257-9. PubMed ID: 6219470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of the reactions between streptokinase, plasmin and alpha 2-antiplasmin.
    Cederholm-Williams SA; De Cock F; Lijnen HR; Collen D
    Eur J Biochem; 1979 Oct; 100(1):125-32. PubMed ID: 158524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ENHANCEMENT OF FIBRINOLYSIS AND ANTAGONISM OF ANTIPLASMIN BY REVERSIBLE PLASMIN INHIBITORS.
    MAXWELL RE; LEWANDOWSKI V; NICKEL VS
    Life Sci (1962); 1965 Jan; 4():45-51. PubMed ID: 14257064
    [No Abstract]   [Full Text] [Related]  

  • 8. Circular dichroism studies on alpha 2-antiplasmin and its interactions with plasmin and plasminogen.
    Nilsson T; Sjöholm I; Wiman B
    Biochim Biophys Acta; 1982 Jul; 705(2):264-70. PubMed ID: 6214280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of plasmin and its complexes with alpha 2-antiplasmin and alpha 2-macroglobulin on secretion of proteinase and plasminogen inhibitors from peripheral mononuclear cells].
    Zhabin SG; Zorin NA; Musatov MI
    Vopr Med Khim; 1995; 41(3):34-7. PubMed ID: 8585176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmin's peptide-binding specificity: characterization of ligand sites in alpha 2-antiplasmin.
    Hortin GL; Trimpe BL; Fok KF
    Thromb Res; 1989 Jun; 54(6):621-32. PubMed ID: 2551057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of plasmin inhibition in the presence of a synthetic tripeptide substrate. The reaction with pancreatic trypsin inhibitor and two forms of alpha 2-plasmin inhibitor.
    Petersen LC; Clemmensen I
    Biochem J; 1981 Oct; 199(1):121-7. PubMed ID: 6175313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanism of the reaction between human alpha 2-antiplasmin and plasmin.
    Wiman B; Collen D
    J Biol Chem; 1979 Sep; 254(18):9291-7. PubMed ID: 158022
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of the antiplasmin activity of human thrombospondin-1 in solution.
    Anonick PK; Yoo JK; Webb DJ; Gonias SL
    Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):903-9. PubMed ID: 7679575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activity.
    Holmes WE; Lijnen HR; Nelles L; Kluft C; Nieuwenhuis HK; Rijken DC; Collen D
    Science; 1987 Oct; 238(4824):209-11. PubMed ID: 2958938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of amino acids in antiplasmin involved in its noncovalent 'lysine-binding-site'-dependent interaction with plasmin.
    Wang H; Yu A; Wiman B; Pap S
    Eur J Biochem; 2003 May; 270(9):2023-9. PubMed ID: 12709062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [STUDIES ON TRYPSIN INHIBITOR AND ANTIPLASMIN IN HUMAN SERUM. I. ON NORMAL AND ARTERIOSCLEROTIC CASES].
    MATSUDA T
    Nihon Ketsueki Gakkai Zasshi; 1963 Oct; 26():581-9. PubMed ID: 14095688
    [No Abstract]   [Full Text] [Related]  

  • 17. The interaction in human plasma of antiplasmin, the fast-reacting plasmin inhibitor, with plasmin, thrombin, trypsin and chymotrypsin.
    Edy J; Collen D
    Biochim Biophys Acta; 1977 Oct; 484(2):423-32. PubMed ID: 143966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine alpha 2-antiplasmin. N-terminal and reactive site sequence.
    Christensen S; Sottrup-Jensen L
    FEBS Lett; 1992 Nov; 312(1):100-4. PubMed ID: 1385210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.